TAIPEI, Jan. 13, 2025 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announces that the U.S. Food and Drug Administration (FDA) issued a Day-74 letter. The Day-74 letter states that the PDUFA goal date for a decision on marketing approval for the 3-month version of...
Hence then, the article about foresee pharmaceuticals announces the pdufa goal date for the 3 month version of camcevi is august 29 2025 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Foresee Pharmaceuticals Announces the PDUFA Goal Date for the 3-month Version of CAMCEVI is August 29, 2025 )
Also on site :
- European ‘propaganda’ using Russia as ‘external enemy’ to mask crises – Kremlin
- 13 Dairy Queen Items You Forgot About
- I’ve Been Drinking Ka’Chava Shakes for 2 Months—Here’s My Honest Take